One-Year Breast Cancer Relative Survival Rates
Michigan Residents,1995-2009

Table 61-A
All Races, Female
Year of
Diagnosis 		All Stages Localized Regional Distant Unknown
Michigan SEER Michigan SEER Michigan SEER Michigan SEER Michigan SEER
2009 95.2 ±0.5 96.8 ±0.1 99.8 ±0.4 100.0 ±0.1 96.5 ±0.8 98.5 ±0.2 61.2 ±3.7 67.3 ±1.2 68.8 ±5.3 67.6 ±2.6
2008 96.8 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 97.6 ±0.5 98.6 ±0.1 69.2 ±2.6 71.7 ±0.9 74.9 ±3.6 75.9 ±1.8
2007 96.5 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 97.4 ±0.5 98.4 ±0.1 67.0 ±2.8 72.4 ±0.9 63.9 ±3.7 74.7 ±1.8
2006 96.6 ±0.3 97.7 ±0.1 100.0 ±0.2 100.0 ±0.1 97.4 ±0.5 98.5 ±0.1 60.0 ±2.8 72.0 ±0.9 82.8 ±3.1 78.2 ±1.7
2005 97.1 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 98.4 ±0.4 98.4 ±0.2 55.3 ±3.1 70.8 ±0.9 84.1 ±2.5 78.0 ±1.7
2004 96.4 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 98.3 ±0.4 98.5 ±0.1 64.7 ±3.0 70.5 ±0.9 71.1 ±2.6 79.8 ±1.6
2003 96.1 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 98.0 ±0.5 98.5 ±0.1 63.3 ±3.3 68.7 ±0.9 64.7 ±2.6 81.4 ±1.4
2002 96.7 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 97.4 ±0.5 98.2 ±0.2 57.1 ±3.2 69.9 ±0.9 81.1 ±2.5 82.0 ±1.4
2001 96.6 ±0.3 97.5 ±0.1 100.0 ±0.2 100.0 ±0.1 97.0 ±0.5 98.4 ±0.1 62.2 ±3.0 68.4 ±0.9 87.6 ±1.8 84.6 ±1.3
2000 96.7 ±0.3 97.4 ±0.1 100.0 ±0.2 100.0 ±0.1 96.8 ±0.5 98.4 ±0.2 58.8 ±3.2 67.5 ±0.9 87.0 ±2.0 86.7 ±1.1
1999 96.7 ±0.3 97.8 ±0.1 100.0 ±0.2 100.0 ±0.1 97.0 ±0.5 98.0 ±0.2 59.7 ±3.2 69.0 ±1.4 85.3 ±2.0 82.0 ±2.1
1998 96.4 ±0.3 97.7 ±0.1 99.6 ±0.3 100.0 ±0.1 98.2 ±0.5 98.3 ±0.2 60.7 ±3.0 69.9 ±1.4 85.5 ±1.8 81.1 ±2.0
1997 96.0 ±0.3 97.5 ±0.1 99.9 ±0.2 100.0 ±0.1 96.9 ±0.5 98.1 ±0.2 53.4 ±3.2 68.5 ±1.4 84.9 ±1.8 85.4 ±1.6
1996 95.4 ±0.3 97.4 ±0.1 99.9 ±0.2 100.0 ±0.1 97.0 ±0.6 98.0 ±0.2 52.1 ±3.1 66.2 ±1.4 80.5 ±2.1 88.2 ±1.6
1995 96.0 ±0.3 97.3 ±0.2 100.0 ±0.2 100.0 ±0.1 96.7 ±0.6 98.2 ±0.2 56.7 ±3.2 65.0 ±1.5 86.2 ±1.6 87.0 ±1.6
                     

Table 61-B
White Female
Year of
Diagnosis 		All Stages Localized Regional Distant Unknown
Michigan SEER Michigan SEER Michigan SEER Michigan SEER Michigan SEER
2009 95.3 ±0.5 97.0 ±0.2 99.9 ±0.4 100.0 ±0.1 96.4 ±0.9 98.7 ±0.2 61.3 ±4.1 67.4 ±1.3 63.4 ±6.5 66.0 ±3.1
2008 97.1 ±0.3 97.7 ±0.1 100.0 ±0.2 100.0 ±0.1 97.9 ±0.5 98.8 ±0.2 68.8 ±2.9 72.2 ±1.0 71.4 ±4.1 70.7 ±2.3
2007 96.7 ±0.3 97.8 ±0.1 100.0 ±0.2 100.0 ±0.1 97.4 ±0.5 98.5 ±0.2 68.5 ±3.1 73.6 ±1.0 61.1 ±4.1 71.4 ±2.1
2006 97.2 ±0.3 98.0 ±0.1 100.0 ±0.2 100.0 ±0.1 97.5 ±0.5 98.7 ±0.2 62.3 ±3.2 73.6 ±1.0 83.8 ±3.4 75.2 ±2.0
2005 97.3 ±0.3 97.9 ±0.1 100.0 ±0.2 100.0 ±0.1 98.4 ±0.5 98.5 ±0.2 55.8 ±3.5 73.0 ±1.0 82.3 ±2.8 76.2 ±2.0
2004 96.8 ±0.3 97.8 ±0.1 100.0 ±0.2 100.0 ±0.1 98.3 ±0.5 98.8 ±0.2 64.3 ±3.4 71.2 ±1.0 73.4 ±2.8 79.2 ±1.8
2003 96.2 ±0.3 97.8 ±0.1 100.0 ±0.2 100.0 ±0.1 98.1 ±0.5 98.7 ±0.2 60.5 ±3.9 69.6 ±1.1 62.7 ±2.8 80.2 ±1.7
2002 97.2 ±0.3 97.7 ±0.1 100.0 ±0.2 100.0 ±0.1 97.9 ±0.5 98.2 ±0.2 61.1 ±3.6 70.8 ±1.0 80.5 ±2.7 81.2 ±1.6
2001 96.9 ±0.3 97.8 ±0.1 100.0 ±0.3 100.0 ±0.1 97.5 ±0.5 98.6 ±0.2 61.0 ±3.3 69.0 ±1.0 88.0 ±1.9 84.8 ±1.4
2000 97.3 ±0.3 97.7 ±0.1 100.0 ±0.2 100.0 ±0.1 97.5 ±0.5 98.6 ±0.2 60.6 ±3.6 68.0 ±1.0 86.9 ±2.2 86.1 ±1.3
1999 96.8 ±0.3 98.0 ±0.1 100.0 ±0.2 100.0 ±0.1 97.2 ±0.6 98.2 ±0.2 58.8 ±3.6 68.6 ±1.5 85.2 ±2.1 81.6 ±2.4
1998 96.8 ±0.3 97.9 ±0.2 99.7 ±0.3 100.0 ±0.1 98.4 ±0.5 98.4 ±0.3 61.4 ±3.3 71.1 ±1.5 86.6 ±1.9 79.4 ±2.4
1997 96.6 ±0.3 97.7 ±0.2 100.0 ±0.3 100.0 ±0.1 97.4 ±0.6 98.3 ±0.3 53.9 ±3.6 69.4 ±1.5 87.1 ±1.9 84.3 ±1.9
1996 95.6 ±0.4 97.7 ±0.2 99.9 ±0.3 100.0 ±0.1 97.1 ±0.6 98.2 ±0.3 53.5 ±3.4 68.2 ±1.6 81.3 ±2.1 86.9 ±1.9
1995 96.3 ±0.3 97.6 ±0.2 100.0 ±0.3 100.0 ±0.1 97.2 ±0.6 98.4 ±0.3 55.8 ±3.4 66.4 ±1.6 86.6 ±1.8 86.7 ±1.9
                     

Table 61-C
Black Female
Year of
Diagnosis 		All Stages Localized Regional Distant Unknown
Michigan SEER Michigan SEER Michigan SEER Michigan SEER Michigan SEER
2009 93.2 ±1.6 94.3 ±0.5 99.3 ±1.2 99.9 ±0.4 97.0 ±2.1 97.4 ±0.7 61.6 ±8.3 64.1 ±2.9 * 64.1 ±7.4
2008 94.1 ±1.0 95.1 ±0.4 98.8 ±0.9 99.5 ±0.3 95.6 ±1.5 97.5 ±0.5 66.7 ±6.2 65.2 ±2.2 * 81.1 ±4.9
2007 92.8 ±1.1 95.1 ±0.4 98.0 ±1.1 99.7 ±0.3 96.1 ±1.5 97.5 ±0.5 59.9 ±6.3 64.4 ±2.2 * 80.4 ±4.8
2006 92.4 ±1.1 94.3 ±0.4 98.8 ±0.9 99.3 ±0.3 96.5 ±1.3 96.7 ±0.5 50.5 ±6.1 61.3 ±2.3 70.4 ±9.6 83.7 ±4.3
2005 95.2 ±1.0 93.7 ±0.4 100.0 ±0.8 99.0 ±0.4 97.8 ±1.3 96.9 ±0.6 56.5 ±6.4 60.3 ±2.3 96.8 ±4.4 80.0 ±5.0
2004 93.4 ±1.1 94.4 ±0.4 100.0 ±0.7 99.7 ±0.3 97.9 ±1.3 96.8 ±0.5 69.1 ±6.1 62.4 ±2.3 52.0 ±7.6 78.6 ±4.5
2003 94.6 ±1.0 94.6 ±0.4 99.8 ±0.8 99.7 ±0.3 96.9 ±1.4 96.8 ±0.5 71.3 ±6.4 64.7 ±2.4 73.0 ±6.9 81.1 ±3.9
2002 92.3 ±1.2 95.0 ±0.4 100.0 ±0.7 100.0 ±0.3 93.6 ±1.7 97.5 ±0.5 42.8 ±6.5 61.8 ±2.5 80.0 ±8.7 79.3 ±4.0
2001 93.8 ±1.1 94.7 ±0.4 100.0 ±0.8 100.0 ±0.3 93.3 ±1.8 96.3 ±0.6 63.6 ±7.0 65.7 ±2.4 75.8 ±8.4 82.0 ±4.0
2000 92.0 ±1.2 94.3 ±0.4 98.7 ±1.0 99.2 ±0.4 92.6 ±1.9 96.1 ±0.6 50.4 ±7.1 62.7 ±2.5 82.9 ±6.2 87.6 ±3.2
1999 95.1 ±1.0 95.3 ±0.6 100.0 ±0.7 100.0 ±0.4 95.4 ±1.5 95.9 ±0.9 57.9 ±8.1 66.5 ±3.8 83.2 ±6.5 79.7 ±6.8
1998 93.8 ±1.1 95.0 ±0.6 98.4 ±1.1 99.8 ±0.5 97.8 ±1.2 96.9 ±0.9 56.1 ±7.9 60.7 ±4.0 71.0 ±7.1 83.6 ±4.7
1997 91.2 ±1.2 94.5 ±0.6 99.1 ±0.9 99.8 ±0.5 94.0 ±1.8 96.6 ±0.9 48.8 ±7.2 58.5 ±4.0 65.9 ±6.7 86.0 ±4.4
1996 92.9 ±1.2 94.1 ±0.6 100.0 ±0.7 99.8 ±0.5 95.9 ±1.7 95.8 ±1.0 47.3 ±7.1 56.1 ±3.9 63.8 ±9.1 95.1 ±3.4
1995 93.7 ±1.1 94.7 ±0.6 100.0 ±0.8 100.0 ±0.5 93.0 ±2.0 95.9 ±1.0 59.6 ±8.4 57.0 ±4.4 80.7 ±5.2 82.6 ±4.7
                     



Notes:

Relative survival:Cancer survival in the absence of other causes of death is calculated using survival life tables. Relative survival is defined as the ratio of the proportion of observed survivors (all causes of death) in a cohort of cancer patients to the proportion of expected survivors in a comparable cohort of cancer-free individuals. The formulation is based on the assumption of independent competing causes of death. Since a cohort of cancer-free individuals is difficult to obtain, we use expected life tables and assume that the cancer deaths are a negligible proportion of all deaths.

*: Figure does not meet standards of reliability or precision.


Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel.

Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes.

Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes.


Source of Michigan Data: Michigan Department of Health and Human Services, Vital Records and Health Data Development Section. Survival data from the Michigan Cancer Surveillance Program are developed through passive surveillance of mortality by matching the registry with state and national mortality files.
Source of SEER Data: National Cancer Institute, Bethesda, MD
Last Updated:: December 13, 2012